We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Ms
Samantha
Roberts
+44 (0)1480 453 437
samantha.roberts@cyted.ai
Dr
Sarah
Killcoyne
+44 (0)1480 453 437
sarah.killcoyne@cyted.ai
Eosinophilic oesophagitis (EoE)
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Eosinophilic oesophagitis (EoE) is a disease of the oesophagus (“food pipe”) affecting tens of thousands of adults and children across the UK. Related to asthma, allergies and other chronic inflammatory conditions, this disease has been on the rise in recent years. However, it can often take years and even several trips to A&E due to food getting stuck in the oesophagus before a diagnosis is made. Treatments are available, but not all patients respond to treatment and the only way to check response is an invasive endoscopy. Finding the right treatment can take multiple endoscopies in a single year, and even after one is found a patient may need endoscopies throughout their life. This study aims to improve patient care in EoE in two ways: by decreasing the need for endoscopy through the use of minimally-invasive capsule sponge testing to collect cells from the oesophagus, and by providing a personalised predictive test for therapy response.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
You can take part if:
You may not be able to take part if:
1. Age <18 years2. Strictures or severe rings at most recent endoscopy that prevent passage of adult 9.8 mm gastroscope3. Oesophageal dilatation within 24 months of clinic visit4. Previous oesophageal perforation or surgical resection5. Oesophagogastric malignancy 6. Oesophageal varices7. Bolus obstruction since last endoscopy requiring hospital visit8. Previous fundoplication or complicated hiatus hernia9. Patient on warfarin with INR>=3
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Ms
Samantha
Roberts
+44 (0)1480 453 437
samantha.roberts@cyted.ai
Dr
Sarah
Killcoyne
+44 (0)1480 453 437
sarah.killcoyne@cyted.ai
The study is sponsored by Cyted Ltd and funded by Innovate UK.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Or CPMS 59420
You can print or share the study information with your GP/healthcare provider or contact the research team directly.